{"id":"W3161231300","doi":"10.1016/j.jgar.2021.03.025","title":"Real-life experience with ceftolozane/tazobactam in Canada: results from the CLEAR (Canadian LEadership on Antimicrobial Real-life usage) registry","year":2021,"lang":"en","type":"article","venue":"Journal of Global Antimicrobial Resistance","topic":"Antibiotic Resistance in Bacteria","field":"Biochemistry, Genetics and Molecular Biology","cited_by":15,"is_retracted":false,"has_abstract":true,"ca_institutions":"St. Boniface Hospital; Moncton Hospital; University of Manitoba; Centre intégré universitaire de santé et de services sociaux de l'Est-de-l'Île-de-Montréal; Centre Intégré Universitaire de Santé et de Services Sociaux du Centre-Sud-de-l'Île-de-Montréal; Hamilton Health Sciences; Ottawa Hospital; Health Sciences Centre; William Osler Health System; University of Alberta; Royal University Hospital; London Health Sciences Centre","funders":"Merck Canada; Basilea Pharmaceutica; Meso Scale Diagnostics; Angelini Pharma; Astellas Pharma Canada; Gilead Sciences; Roche; Shionogi; Merck; University of Manitoba; Bayer; Pfizer","keywords":"Medicine; Tazobactam; Colistin; Pneumonia; Antimicrobial; Intensive care medicine; Internal medicine; Antibiotics; Antibiotic resistance; Microbiology; Biology; Imipenem","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001222186,0.0002889101,0.0003812437,0.001169376,0.001431029,0.001578288,0.0009451124,0.0004476614,0.001912784],"category_scores_gemma":[0.006811757,0.0003272494,0.0003938008,0.004477923,0.000788542,0.0005191816,0.001122358,0.000627423,0.0003646436],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.02429409,"about_ca_system_score_gemma":0.03805537,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.9794911,"about_ca_topic_score_gemma":0.9828175,"domain_scores_codex":[0.9968861,0.0002947797,0.00023971,0.0002469732,0.001618333,0.0007141496],"domain_scores_gemma":[0.9882268,0.0007346493,0.003283098,0.00030102,0.005167255,0.002287209],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0001846933,0.00009576025,0.9826638,0.00008616578,0.00004541089,0.0001726909,0.001203933,0.0001874651,0.0001298278,0.00007398431,0.003783298,0.01137296],"study_design_scores_gemma":[0.00002713831,0.00007102981,0.9943914,0.00005307285,0.00002785382,0.0001584907,0.001617179,0.0004609242,0.0001120755,0.00001236297,0.003046786,0.0000218812],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9805136,0.0009838893,0.0001902463,0.0008596317,0.00001488247,0.000115342,0.01436389,0.00003147655,0.002927042],"genre_scores_gemma":[0.9911215,0.001141062,0.0002791703,0.0003190488,0.00001273226,0.000032578,0.006334302,0.00001804784,0.0007415423],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.9794911,"threshold_uncertainty_score":0.1762667,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0185328351067521,"score_gpt":0.2348561267657132,"score_spread":0.2163232916589611,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}